Sovan Dey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sovan Dey has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Firoj Hossain
Department of Chemistry, University of North Bengal, Raja Rammohunpur, Darjeeling-734013, India
6 shared publications - Ram Naresh Yadav
Department of Chemistry, Faculty of Engineering and Technology, Veer Bahadur Singh Purvanchal University, Jaunpur-222003, UP, India
6 shared publications - Amit Kumar Paul
Department of Chemical Science Unified Academic Campus Bose Institute Kolkata India
3 shared publications Anup Barman
Department of Chemistry University of North Bengal Darjeeling West Bengal India
2 shared publications- Arindam Das
Department of Chemistry, University of North Bengal, Raja Rammohunpur, Darjeeling-734013, India
2 shared publications - Koushik Sarkar
Department of Chemical Sciences, IISER Kolkata, Mohanpur-741246, Nadia, WB, India
2 shared publications
Latest Publications
- 21 October 2026
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 24 (40) , 8246-8250
Photochemical C–C bond cleavage in α-haloketones via a pyridinium ylide radical: direct access to esters and amides
We report a visible-light-induced C–C bond cleavage of α-haloketones, yielding esters and amides by harnessing pyridinium ylide diradicals.
- 21 October 2026
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 24 (40) , 8246-8250
Photochemical C–C bond cleavage in α-haloketones via a pyridinium ylide radical: direct access to esters and amides
We report a visible-light-induced C–C bond cleavage of α-haloketones, yielding esters and amides by harnessing pyridinium ylide diradicals.
- Open Access
- 31 August 2026
- Published by Wiley in ChemBioChem
- Vol. 27 (17) , e70492
Sustainable Biocatalytic Cascades: A Versatile Tool in the Synthesis of Natural Products With Therapeutic Potential
Biocascade catalysis has emerged as a defining paradigm in contemporary synthesis, enabling the orchestration of multiple enzymatic transformations within a single vessel. By allowing intermediates to flow seamlessly between successive steps without isolation, cascades emulate the elegance of natural biosynthetic networks while delivering significant gains in atom economy and operational simplicity. The intrinsic chemo‐, regio‐, and stereoselectivity of enzymes facilitates the construction of architecturally complex, enantiomerically enriched molecules under mild, aqueous, and environmentally benign conditions. In this way, biocascade strategies accelerate the generation of molecular diversity while embodying the principles of sustainable chemistry by reducing energy demand, solvent use, and waste generation. Recent advances in protein engineering, directed evolution, computational enzyme design, and synthetic biology have expanded the scope of enzymatic cascades, transforming nature's catalytic repertoire into scalable synthetic technologies. Landmark studies now demonstrate their transformative potential in the assembly of complex polyketides, bioactive alkaloids, pharmaceuticals, and active pharmaceutical ingredients (APIs), as well as diverse heterocyclic scaffolds of medicinal relevance. Collectively, these achievements underscore the growing significance of biocascade catalysis as a cornerstone of modern synthesis, bridging the ingenuity of biological systems with the imperatives of next‐generation drug discovery and sustainable chemical manufacturing.
- 31 August 2026
- Published by Wiley in ChemBioChem
- Vol. 27 (17) , e70492
Open AccessSustainable Biocatalytic Cascades: A Versatile Tool in the Synthesis of Natural Products With Therapeutic Potential
Biocascade catalysis has emerged as a defining paradigm in contemporary synthesis, enabling the orchestration of multiple enzymatic transformations within a single vessel. By allowing intermediates to flow seamlessly between successive steps without isolation, cascades emulate the elegance of natural biosynthetic networks while delivering significant gains in atom economy and operational simplicity. The intrinsic chemo‐, regio‐, and stereoselectivity of enzymes facilitates the construction of architecturally complex, enantiomerically enriched molecules under mild, aqueous, and environmentally benign conditions. In this way, biocascade strategies accelerate the generation of molecular diversity while embodying the principles of sustainable chemistry by reducing energy demand, solvent use, and waste generation. Recent advances in protein engineering, directed evolution, computational enzyme design, and synthetic biology have expanded the scope of enzymatic cascades, transforming nature's catalytic repertoire into scalable synthetic technologies. Landmark studies now demonstrate their transformative potential in the assembly of complex polyketides, bioactive alkaloids, pharmaceuticals, and active pharmaceutical ingredients (APIs), as well as diverse heterocyclic scaffolds of medicinal relevance. Collectively, these achievements underscore the growing significance of biocascade catalysis as a cornerstone of modern synthesis, bridging the ingenuity of biological systems with the imperatives of next‐generation drug discovery and sustainable chemical manufacturing.
- 23 February 2026
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 17 (3) , 1397-1444
Empowering molecular complexity via biocatalysis: emerging blueprints in the total synthesis of medicinally relevant natural products
Biocatalysis has ascended as a defining force in contemporary total synthesis, furnishing catalytic modalities that deliver molecular complexity with unparalleled chemo-, regio-, and stereo-control.
- 23 February 2026
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 17 (3) , 1397-1444
Empowering molecular complexity via biocatalysis: emerging blueprints in the total synthesis of medicinally relevant natural products
Biocatalysis has ascended as a defining force in contemporary total synthesis, furnishing catalytic modalities that deliver molecular complexity with unparalleled chemo-, regio-, and stereo-control.
- 11 October 2025
- Published by Wiley in ChemCatChem
- Vol. 17 (23)
Composition‐Engineered Quantum Dots for Visible Light‐Driven Copper‐Catalyzed Click Chemistry
Quantum dots (QDs) are emerging as high‐performance photocatalysts, surpassing conventional systems through their superior light‐harvesting efficiency, tunable electronic properties, and robust charge carrier dynamics. Here, compositionally tuned Zn x Cd 1‐x S QDs ( x = 0.0–1.0) are systematically optimized for visible light‐driven copper‐catalyzed azide–alkyne cycloaddition (CuAAC), a pivotal reaction in organic synthesis. Zn 0 . 1 Cd 0 . 9 S QDs ( x = 0.1) exhibit an exceptional 99.5% triazole yield within 4 h, significantly outperforming conventional CdS QDs (6 h). Their finely tuned 2.72 eV bandgap, precisely aligned with 456 nm blue light, enhances charge separation and accelerates catalytic efficiency. These QDs demonstrate broad substrate scope, excellent functional group tolerance, high recyclability (81% efficiency over 10 cycles), and scalability (93% gram‐scale yield), maintaining structural integrity as confirmed by morphological and spectroscopic analyses. This work establishes compositionally engineered QDs as advanced, durable photocatalysts, providing a transformative approach to sustainable CuAAC chemistry and broader nanomaterial‐driven applications.
- 11 October 2025
- Published by Wiley in ChemCatChem
- Vol. 17 (23)
Composition‐Engineered Quantum Dots for Visible Light‐Driven Copper‐Catalyzed Click Chemistry
Quantum dots (QDs) are emerging as high‐performance photocatalysts, surpassing conventional systems through their superior light‐harvesting efficiency, tunable electronic properties, and robust charge carrier dynamics. Here, compositionally tuned Zn x Cd 1‐x S QDs ( x = 0.0–1.0) are systematically optimized for visible light‐driven copper‐catalyzed azide–alkyne cycloaddition (CuAAC), a pivotal reaction in organic synthesis. Zn 0 . 1 Cd 0 . 9 S QDs ( x = 0.1) exhibit an exceptional 99.5% triazole yield within 4 h, significantly outperforming conventional CdS QDs (6 h). Their finely tuned 2.72 eV bandgap, precisely aligned with 456 nm blue light, enhances charge separation and accelerates catalytic efficiency. These QDs demonstrate broad substrate scope, excellent functional group tolerance, high recyclability (81% efficiency over 10 cycles), and scalability (93% gram‐scale yield), maintaining structural integrity as confirmed by morphological and spectroscopic analyses. This work establishes compositionally engineered QDs as advanced, durable photocatalysts, providing a transformative approach to sustainable CuAAC chemistry and broader nanomaterial‐driven applications.
- 17 October 2024
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 60 (97) , 14384-14387
Electron donor–acceptor complex enabled photocascade strategy for the synthesis of trans-dihydrofuro[3,2-c]chromen-4-one scaffolds via radical conjugate addition of pyridinium ylide
A photocascade strategy is disclosed for the synthesis of trans-dihydrofurocoumarin utilising the EDA complex followed by 1,4-radical conjugate addition of pyridinium ylide.
- 17 October 2024
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 60 (97) , 14384-14387
Electron donor–acceptor complex enabled photocascade strategy for the synthesis of trans-dihydrofuro[3,2-c]chromen-4-one scaffolds via radical conjugate addition of pyridinium ylide
A photocascade strategy is disclosed for the synthesis of trans-dihydrofurocoumarin utilising the EDA complex followed by 1,4-radical conjugate addition of pyridinium ylide.
- 12 March 2024
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 48 (17) , 7566-7578
Unleashing naphthopyranopyrimidine's anticancer potential: a deep eutectic solvent (DES) study
This study unveils a novel eco-friendly synthesis of naphthopyranopyrimidines using DES. These compounds exhibit promising antiproliferative activity against HepG2 and MCF7 cell lines, as evidenced by IC50 assays. Docking studies shed light on their potential as therapeutic agents.
- 12 March 2024
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 48 (17) , 7566-7578
Unleashing naphthopyranopyrimidine's anticancer potential: a deep eutectic solvent (DES) study
This study unveils a novel eco-friendly synthesis of naphthopyranopyrimidines using DES. These compounds exhibit promising antiproliferative activity against HepG2 and MCF7 cell lines, as evidenced by IC50 assays. Docking studies shed light on their potential as therapeutic agents.